S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
Laser breakthrough could send stock soaring 2,467% (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Asian shares mostly rise despite worries about US debt talks
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
TSE:NWH.UN

NorthWest Health Prop Real Est Inv Trust (NWH.UN) Price Target & Analyst Ratings

C$7.85
-0.02 (-0.25%)
(As of 05/19/2023 08:49 PM ET)
Compare
Today's Range
C$7.82
C$7.90
50-Day Range
C$7.81
C$9.31
52-Week Range
C$7.78
C$13.42
Volume
375,264 shs
Average Volume
793,159 shs
Market Capitalization
C$1.89 billion
P/E Ratio
29.07
Dividend Yield
10.19%
Price Target
C$11.14

NorthWest Health Prop Real Est Inv Trust Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

C$11.14
41.95% Upside
High PredictionC$15.50
Average PredictionC$11.14
Low PredictionC$8.50
TypeCurrent
5/22/22 to 5/22/23
1 Month Ago
4/22/22 to 4/22/23
3 Months Ago
2/21/22 to 2/21/23
1 Year Ago
5/22/21 to 5/22/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetC$11.14C$11.50C$13.56C$15.38
Predicted Upside41.95% Upside23.22% Upside16.55% Upside10.66% Upside
Get NorthWest Health Prop Real Est Inv Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NWH.UN and its competitors with MarketBeat's FREE daily newsletter.


NWH.UN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NWH.UN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

NorthWest Health Prop Real Est Inv Trust Stock vs. The Competition

TypeNorthWest Health Prop Real Est Inv TrustReal Estate Companies
Consensus Rating Score
2.40
2.43
Consensus RatingHoldHold
News Sentiment RatingNeutral News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/19/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector PerformC$10.00 ➝ C$9.00+14.80%
5/16/2023National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetSector PerformC$9.00 ➝ C$8.50+7.19%
4/28/2023CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$12.00 ➝ C$11.00+34.80%
4/5/2023BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$11.00 ➝ C$10.00+21.36%
4/4/2023Laurentian
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$12.50 ➝ C$11.00+33.01%
4/3/2023Cormark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetC$13.50 ➝ C$13.00+54.58%
11/15/2022Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Sector Perform
(Data available from 5/22/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












NWH.UN Price Target - Frequently Asked Questions

What is NorthWest Health Prop Real Est Inv Trust's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for NorthWest Health Prop Real Est Inv Trust stock is Hold based on the current 3 hold ratings and 2 buy ratings for NWH.UN. The average twelve-month price prediction for NorthWest Health Prop Real Est Inv Trust is C$11.14 with a high price target of C$15.50 and a low price target of C$8.50. Learn more on NWH.UN's analyst rating history.

Do Wall Street analysts like NorthWest Health Prop Real Est Inv Trust more than its competitors?

Analysts like NorthWest Health Prop Real Est Inv Trust less than other Real Estate companies. The consensus rating score for NorthWest Health Prop Real Est Inv Trust is 2.40 while the average consensus rating score for real estate companies is 2.43. Learn more on how NWH.UN compares to other companies.

Does NorthWest Health Prop Real Est Inv Trust's stock price have much upside?

According to analysts, NorthWest Health Prop Real Est Inv Trust's stock has a predicted upside of 22.19% based on their 12-month price targets.

What analysts cover NorthWest Health Prop Real Est Inv Trust?

NorthWest Health Prop Real Est Inv Trust has been rated by BMO Capital Markets, CIBC, Cormark, Laurentian, National Bankshares, and Royal Bank of Canada in the past 90 days.


Stock Ratings Reports and Tools

This page (TSE:NWH.UN) was last updated on 5/22/2023 by MarketBeat.com Staff

My Account -